Drug Trial Radar · NCT02217410
CCFZ533X2201 - PoC Study in de Novo Renal Transplantation
Last checked: Nov 19, 2026Latest source record: Sep 28, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
59
Actual
Start
Feb 5, 2015
Primary completion
Nov 29, 2017
Study completion Nov 29, 2017
Sponsor
- Lead sponsor
- Novartis PharmaceuticalsNovartis (NVS)
- Sponsor type
- Industry
- First posted
- Aug 15, 2014
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Basic science
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study was to investigate the safety, tolerability, pharmacokinetics (PK) and potential for CFZ533 to replace calcineurin inhibitors (CNI), while providing a similar rate of acute rejection prophylaxis and renal function in a de novo renal transplant population receiving an allograft from standard criteria donors.
Conditions
- Kidney Transplantation
Interventions
CFZ533Biological
Tacrolimus (Tac)Drug
Mycophenolate mofetil (MMF)Drug
Corticosteroids (CS)Drug
anti-IL2 InductionBiological
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean Cmax Pharmacokinetic Parameter- Part ITime frame: Day 1
- Mean Tmax Pharmacokinetic Parameter - Part ITime frame: Day 1
- Mean AUClast Pharmacokinetic Parameter - Part ITime frame: Day 1
- Efficacy as Defined by the Frequency and Severity (Banff Classification) of Treated Biopsy Proven Acute Rejection (tBPAR) Adjudicated Data - Part IITime frame: 3, 6, 9, and 12 months
Locations
14 sites in 4 countries. Site status is shown where the registry gives one.
Novartis Investigative Site
Aurora, Colorado
Novartis Investigative Site
Baltimore, Maryland
Novartis Investigative Site
Ann Arbor, Michigan
Novartis Investigative Site
Detroit, Michigan
Novartis Investigative Site
Livingston, New Jersey
Novartis Investigative Site
Cincinnati, Ohio
Novartis Investigative Site
São Paulo, São Paulo, Brazil
Novartis Investigative Site
Berlin, Germany
Novartis Investigative Site
Essen, Germany
Novartis Investigative Site
Hamburg, Germany
Novartis Investigative Site
Heidelberg, Germany
Novartis Investigative Site
Groningen, Netherlands
Novartis Investigative Site
Rotterdam, Netherlands
Novartis Investigative Site
Utrecht, The Netherlands, Netherlands
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.